ClinicalTrials.gg
Enrolling by invitationNCT07387393Updated Jun 9, 2026

To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years

An interventional study of PILI (Partnership for Improving Lifestyle Intervention) Pasifika Program in Cardiometabolic Conditions, Hypertension (HTN) and Dyslipidemia, sponsored by University of Hawaii. Enrolling by invitation at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-09.

Sponsored by University of Hawaii · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this study, the investigators are conducting a Type 3 hybrid effectiveness-implementation trial to evaluate the implementation of the Community Health Workers (CHW)-delivered PILI Pasifika Program (PPP) across 3 regions, the U.S. Affiliated Pacific Islands (USAPI), the continental U.S., and Hawai'i, among 400 Native Hawaiian and Pacific Islander (NHPI) participants in two settings, (clinical and non-clinical) over a 3-year period. The PPP is a 3-month lifestyle intervention that includes a Social Determinants of Health (SDOH) component and was NHPI-adapted from the Diabetes Prevention Program's Lifestyle Program, renamed to the PILI Lifestyle Program (PLP), which demonstrated effectiveness in improving weight, blood pressure, physical activity, and diet among NHPIs. The PPP consists of 8 lifestyle lessons and 4 SDOH activities delivered over a 3-month period.

The aims of this study are threefold:

  1. To evaluate the implementation of the PPP across multiple community sites using a Type 3 hybrid effectiveness-implementation design guided by established frameworks such as RE-AIM and PRISM.
  2. To examine participant-level outcomes associated with PPP implementation, including changes in cardiometabolic risk factors, health behaviors, and SDOH factors from baseline to 3 and 9-month follow-up.
  3. To evaluate the cost and cost-effectiveness of implementing the PPP across community settings.
Read the detailed description

Native Hawaiians and Pacific Islanders (NHPIs) continue to disproportionally experience high rates of cardiometabolic conditions, including obesity, hypertension, type 2 diabetes, and cardiovascular disease. To address these inequities, the Diabetes Prevention Program's Lifestyle Intervention (DPP-LI) was developed and subsequently culturally and contextually adapted into the PILI Lifestyle Program (PLP). Through consolidation and collaboration with NHPIs to revamp the DPP-LI, the original 16 lessons were modified into 8 lessons delivered over a 3-month period. These lessons offer empirically supported strategies, based on the Social Cognitive Theory, to improve healthy eating, physical activity, and time and stress management.

Community Health Workers (CHWs) serve as frontline public health workers and trusted community resources who can effectively disseminate and implement cardiometabolic-related interventions across diverse settings. The trusting relationship CHWs have with communities enables them to serve as a liaison and intermediaries between health, social, and cultural services and the community, facilitating access to services and improving their quality and cultural competence. NHPI CHWs are uniquely positioned to deliver effective interventions that improve cardiometabolic health outcomes and address their social determinants.

The PLP was adapted to include a Social Determinants of Health (SDOH) component and evaluated for its effectiveness in ClinicalTrials NCT06471595, resulting in what is now known as the PILI Pasifika Program (PPP).

02

Conditions studied

  • Cardiometabolic Conditions
  • Hypertension (HTN)
  • Dyslipidemia
  • Pre-diabetes
  • Type 2 Diabetes Mellitus (T2DM)
  • Overweight (BMI > 25)
  • Weight Loss Trial

Keywords

  • Weight Loss Intervention
  • CHWs
  • Community Health Workers
  • PILI Lifestyle Program
  • Social Determinants of Health
  • U.S. Pacific Jurisdictions
  • Continental U.S.
  • Pacific Islands
  • Hawai'i
  • Education
  • Lifestyle Intervention
  • Community-Based Participatory Research (CBPR)
  • Academic and Community Partnership
  • Native Hawaiians
  • Pacific Islanders
  • PILI Pasifika Program
  • PPP
03

In context

Hypertension

6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.

This study's planned enrollment of 400 is above the median of 100 across 4,575 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

University of Hawaii is the lead sponsor of 97 studies on the registry; 21 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Self-identify as Native Hawaiian or Pacific Islander
  • 18 years of age or older
  • Have at least one of the following self-reported cardiometabolic conditions (Overweight or obesity defined as ≥ 25, pre-diabetes or diabetes, high blood pressure, and/or high cholesterol)
  • Able to do a moderate level of physical activity or exercise

Exclusion criteria

Exclusion Criteria:

  • Do not identify as Native Hawaiian or Pacific Islander
  • Under 18 years of age
  • Currently a student
  • Do not have any of the following conditions (overweight/obesity, pre-diabetes/diabetes, high blood pressure, or high cholesterol)
  • Have special dietary needs/dietary restrictions (due to cultural reasons and/or told by a healthcare provider)
  • Pregnant women
  • Have physical activity limitations/restrictions (told by a healthcare provider)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    PILI Pasifika Program - Clinical Setting

    Participants in this group will engage in a 3-month PILI Pasifika Program (PPP) with a trained Community Health Worker (CHW). Each week during the 3-months, participants will meet for approximately 1-1.5 hours to receive a Weekly Lesson or engage in an SDOH activity. Participants will also complete an assessment at baseline, at the 3-month program completion, and at the 9-month follow-up.

    Behavioral: PILI (Partnership for Improving Lifestyle Intervention) Pasifika Program

  • Experimental
    PILI Pasifika Program - Community (Non-Clinical) Setting

    Participants in this group will engage in a 3-month PILI Pasifika Program (PPP) with a trained Community Health Worker (CHW). Each week during the 3-months, participants will meet for approximately 1-1.5 hours to receive a Weekly Lesson or engage in an SDOH activity. Participants will also complete an assessment at baseline, at the 3-month program completion, and at the 9-month follow-up.

    Behavioral: PILI (Partnership for Improving Lifestyle Intervention) Pasifika Program

Interventions

  • BehavioralPILI (Partnership for Improving Lifestyle Intervention) Pasifika Program

    The PILI Pasifika Program (PPP) is an adapted 3-month behavioral lifestyle intervention with an enhanced social determinants of health (SDOH) component focused on initiating weight loss and addressing social and cultural challenges, such as access to healthy foods, housing, and employment issues, among Native Hawaiians and Pacific Islanders (NHPIs). The 3-month PPP includes 8 lessons that offer empirically supported strategies (e.g., plate method, stimulus control), grounded in Social Cognitive Theory, to improve healthy eating, physical activity, and time and stress management, as well as 4 SDOH activities that guide community needs, such as food access, transportation, and housing throughout the program.

    Also known as: PPP, PILI Pasifika Program, Partnership for Improving Lifestyle Intervention (PILI) + Social Determinants of Health Component

06

What researchers measure

Primary outcomes

  1. Hemoglobin A1C

    A finger stick sample will be collected to measure hemoglobin A1C using the A1CNow+ kit.

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  2. Lipid Panel

    A fingerstick sample will be collected to measure Total Cholesterol, High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL), and Triglycerides using the CardioChek Plus Analyzer.

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  3. Blood Pressure

    Systolic and diastolic blood pressure will both be measured by a digital blood pressure monitor device (Omron HEM-907XL IntelliSense).

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  4. Weight

    Weight will be calculated using a standardized mobile medical flat scale (Seca 876).

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  5. Body Mass Index (BMI)

    Height data will be measured at baseline using a standardized portable stadiometer. Weight will be measured using a standardized mobile medical flat scale. BMI will be calculated.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

Secondary outcomes

  1. Dietary Questionnaire

    A 5-item will be used to estimate the frequency and types of food a participant consumed in the past month. Taken directly from Common Survey IV, the dietary questionnaire consists of 5 items, documenting how many times per week in the past month participants have consumed specific types of food. The responses range from Never, 1-2 times per week, 3-4 times per week, 5-6 times per week, More than 6 times per week, and Don't know.

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  2. Brief Physical Activity Questionnaire

    A 2-item physical activity questionnaire will be used to briefly assess average physical activity behavior per week and the duration of the physical activity.

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  3. Food Literacy Form

    An 11-item questionnaire on food literacy will be used to ask participants' food literacy in regard to planning, managing, selecting, preparing, and eating healthy foods. The responses and scores range from 1-not at all/never, 2-disagree, 3-slightly disagree, 4-slightly agree, 5-yes/always. Higher scores indicate greater food literacy.

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  4. Well-Being Questionnaire

    A 6-item questionnaire used to briefly assess satisfaction of well-being in standard of living, health, past and present achievements in life, personal relationships, safety, and feeling of belonging.

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  5. Food Insecurity Form

    A 7-item questionnaire on food literacy will be used to assess participants' food literacy in regard to planning, managing, selecting, preparing, and eating healthy foods. The responses and scores range from 1-not at all/never, 2-disagree, 3-slightly disagree, 4-slightly agree, 5-yes/always. Higher scores indicate greater food literacy.

    Time frame: Assessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

  6. Food Access Form

    An 11-item food access questionnaire will be used to assess household food access and the frequency with which households experience food-related challenges. Responses of "All the time (every day)", "Pretty often (3-6x per week)", "Once in a while (1-2x per week)", "Hardly at all (\<1x per week)", and "Never". Higher scores indicate lower levels of food access.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

  7. Food Access SDOH Form

    A 5-item form on food access will be used to assess household food access over the past 12 months, including food availability, affordability, and ability to obtain balanced meals.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

  8. Medical Care Access SDOH Form

    A 5-item measure to assess medical healthcare access and utilization, source of care, insurance coverage, cost-related delays, provider availability, and health literacy.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

  9. Dental Care SDOH Form

    A 3-item measure to assess barriers to dental care.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

  10. Housing SDOH Form

    A 4-item measure to assess housing situation.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

  11. Transportation and Environment SDOH Form

    A 4-item measure to assess transportation access and neighborhood environment.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

  12. Social and Emotional Health SDOH Form

    A 4-item measure to assess psychosocial well-being, social connectedness, perceived stress, and perceived safety.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

  13. Health Literacy SDOH Form

    An 18-item measure to assess health literacy.

    Time frame: Assessment data will be collected at baseline and 3-month follow-up.

07

Study locations

2 sites
  • National Association of Pasifika Organizations
    Fayetteville, Arkansas 72704, United States
  • Papa Ola Lokahi
    Honolulu, Hawaii 96813, United States
08

References and documents

Publications

  • Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013 Dec 1;8:139. doi: 10.1186/1748-5908-8-139. PubMed 24289295 ↗
  • Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, Proctor EK, Kirchner JE. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015 Feb 12;10:21. doi: 10.1186/s13012-015-0209-1. PubMed 25889199 ↗
  • Waltz TJ, Powell BJ, Matthieu MM, Damschroder LJ, Chinman MJ, Smith JL, Proctor EK, Kirchner JE. Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study. Implement Sci. 2015 Aug 7;10:109. doi: 10.1186/s13012-015-0295-0. PubMed 26249843 ↗
  • Kaholokula JK, Look M, Mabellos T, Ahn HJ, Choi SY, Sinclair KA, Wills TA, Seto TB, de Silva M. A Cultural Dance Program Improves Hypertension Control and Cardiovascular Disease Risk in Native Hawaiians: A Randomized Controlled Trial. Ann Behav Med. 2021 Oct 4;55(10):1006-1018. doi: 10.1093/abm/kaaa127. PubMed 33677520 ↗
  • DePue JD, Dunsiger S, Seiden AD, Blume J, Rosen RK, Goldstein MG, Nu'usolia O, Tuitele J, McGarvey ST. Nurse-community health worker team improves diabetes care in American Samoa: results of a randomized controlled trial. Diabetes Care. 2013 Jul;36(7):1947-53. doi: 10.2337/dc12-1969. Epub 2013 Feb 7. PubMed 23393217 ↗
  • Rouquette A, Falissard B. Sample size requirements for the internal validation of psychiatric scales. Int J Methods Psychiatr Res. 2011 Dec;20(4):235-49. doi: 10.1002/mpr.352. Epub 2011 Oct 24. PubMed 22020761 ↗
  • Kwan BM, McGinnes HL, Ory MG, Estabrooks PA, Waxmonsky JA, Glasgow RE. RE-AIM in the Real World: Use of the RE-AIM Framework for Program Planning and Evaluation in Clinical and Community Settings. Front Public Health. 2019 Nov 22;7:345. doi: 10.3389/fpubh.2019.00345. eCollection 2019. PubMed 31824911 ↗
  • Gupta N, Verma R, Dhiman RK, Rajsekhar K, Prinja S. Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians. J Clin Exp Hepatol. 2020 Mar-Apr;10(2):177-184. doi: 10.1016/j.jceh.2019.11.001. Epub 2019 Nov 26. PubMed 32189934 ↗
  • Narcisse MR, Felix H, Long CR, Hudson T, Payakachat N, Bursac Z, McElfish PA. Frequency and predictors of health services use by Native Hawaiians and Pacific Islanders: evidence from the U.S. National Health Interview Survey. BMC Health Serv Res. 2018 Jul 21;18(1):575. doi: 10.1186/s12913-018-3368-3. PubMed 30031403 ↗
  • Panapasa SV, Mau MK, Williams DR, McNally JW. Mortality patterns of Native Hawaiians across their lifespan: 1990-2000. Am J Public Health. 2010 Nov;100(11):2304-10. doi: 10.2105/AJPH.2009.183541. Epub 2010 Sep 23. PubMed 20864716 ↗
  • Palafox NA, Reichhardt M, Taitano JR, Nitta M, Garstang H, Riklon S, Taulung L, Buenconsejo-Lum LE. A Socio-Ecological Framework for Cancer Control in the Pacific: A Community Case Study of the US Affiliated Pacific Island Jurisdictions 1997-2017. Front Public Health. 2018 Nov 13;6:313. doi: 10.3389/fpubh.2018.00313. eCollection 2018. PubMed 30483488 ↗
  • Wu Y, Braun K, Onaka AT, Horiuchi BY, Tottori CJ, Wilkens L. Life Expectancies in Hawai'i: A Multi-ethnic Analysis of 2010 Life Tables. Hawaii J Med Public Health. 2017 Jan;76(1):9-14. PubMed 28090398 ↗
  • Nakagawa K, Koenig MA, Seto TB, Asai SM, Chang CW. Racial disparities among Native Hawaiians and Pacific Islanders with intracerebral hemorrhage. Neurology. 2012 Aug 14;79(7):675-80. doi: 10.1212/WNL.0b013e3182608c6f. Epub 2012 Jul 18. PubMed 22815551 ↗
  • McElfish PA, Purvis RS, Esquivel MK, Sinclair KA, Townsend C, Hawley NL, Haggard-Duff LK, Kaholokula JK. Diabetes Disparities and Promising Interventions to Address Diabetes in Native Hawaiian and Pacific Islander Populations. Curr Diab Rep. 2019 Mar 18;19(5):19. doi: 10.1007/s11892-019-1138-1. PubMed 30887399 ↗
  • Mau MK, Keawe'aimoku Kaholokula J, West MR, Leake A, Efird JT, Rose C, Palakiko DM, Yoshimura S, Kekauoha PB, Gomes H. Translating diabetes prevention into native Hawaiian and Pacific Islander communities: the PILI 'Ohana Pilot project. Prog Community Health Partnersh. 2010 Spring;4(1):7-16. doi: 10.1353/cpr.0.0111. PubMed 20364073 ↗
  • Chihara I, Hayes DK, Chock LR, Fuddy LJ, Rosenberg DL, Handler AS. Relationship between gestational weight gain and birthweight among clients enrolled in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), Hawaii, 2003-2005. Matern Child Health J. 2014 Jul;18(5):1123-31. doi: 10.1007/s10995-013-1342-6. PubMed 23917900 ↗
  • Aluli NE, Reyes PW, Brady SK, Tsark JU, Jones KL, Mau M, Howard WJ, Howard BV. All-cause and CVD mortality in Native Hawaiians. Diabetes Res Clin Pract. 2010 Jul;89(1):65-71. doi: 10.1016/j.diabres.2010.03.003. Epub 2010 Apr 14. PubMed 20392507 ↗
  • Long CR, Rowland B, McElfish PA, Ayers BL, Narcisse MR. Food Security Status of Native Hawaiians and Pacific Islanders in the US: Analysis of a National Survey. J Nutr Educ Behav. 2020 Aug;52(8):788-795. doi: 10.1016/j.jneb.2020.01.009. Epub 2020 Mar 14. PubMed 32184077 ↗
  • Watson RE, Karnchanasorn R, Gossain VV. Hypertension in Asian/Pacific Island Americans. J Clin Hypertens (Greenwich). 2009 Mar;11(3):148-52. doi: 10.1111/j.1751-7176.2009.00088.x. PubMed 19302427 ↗
  • Kaholokula JK, Wilson RE, Townsend CK, Zhang GX, Chen J, Yoshimura SR, Dillard A, Yokota JW, Palakiko DM, Gamiao S, Hughes CK, Kekauoha BK, Mau MK. Translating the Diabetes Prevention Program in Native Hawaiian and Pacific Islander communities: the PILI 'Ohana Project. Transl Behav Med. 2014 Jun;4(2):149-59. doi: 10.1007/s13142-013-0244-x. PubMed 24904698 ↗
  • Bacong AM, Holub C, Porotesano L. Comparing Obesity-Related Health Disparities among Native Hawaiians/Pacific Islanders, Asians, and Whites in California: Reinforcing the Need for Data Disaggregation and Operationalization. Hawaii J Med Public Health. 2016 Nov;75(11):337-344. PubMed 27920944 ↗
  • Townsend CK, Miyamoto RE, Antonio M, Zhang G, Paloma D, Basques D, Braun KL, Kaholokula JK. The PILI@Work Program: a translation of the diabetes prevention program to Native Hawaiian-serving worksites in Hawai'i. Transl Behav Med. 2016 Jun;6(2):190-201. doi: 10.1007/s13142-015-0383-3. PubMed 27356989 ↗
  • Tsark JU, Braun KL. Eyes on the Pacific: cancer issues of Native Hawaiians and Pacific Islanders in Hawai'i and the US-associated Pacific. J Cancer Educ. 2009;24(2 Suppl):S68-9. doi: 10.1080/08858190903404619. No abstract available. PubMed 20024833 ↗
  • Saldana L, Chamberlain P, Bradford WD, Campbell M, Landsverk J. The Cost of Implementing New Strategies (COINS): A Method for Mapping Implementation Resources Using the Stages of Implementation Completion. Child Youth Serv Rev. 2014 Apr 1;39:177-182. doi: 10.1016/j.childyouth.2013.10.006. PubMed 24729650 ↗
  • Pittman JOE, Lindamer L, Afari N, Depp C, Villodas M, Hamilton A, Kim B, Mor MK, Almklov E, Gault J, Rabin B. Implementing eScreening for suicide prevention in VA post-9/11 transition programs using a stepped-wedge, mixed-method, hybrid type-II implementation trial: a study protocol. Implement Sci Commun. 2021 Apr 29;2(1):46. doi: 10.1186/s43058-021-00142-9. PubMed 33926577 ↗
  • Malone S, Prewitt K, McKay V, Zabotka L, Bacon C, Luke DA. Lowering the burden: Shorter versions of the Program Sustainability Assessment Tool (PSAT) and Clinical Sustainability Assessment Tool (CSAT). Implement Sci Commun. 2024 Oct 10;5(1):113. doi: 10.1186/s43058-024-00656-y. PubMed 39390536 ↗
  • Ehrhart MG, Aarons GA, Farahnak LR. Assessing the organizational context for EBP implementation: the development and validity testing of the Implementation Climate Scale (ICS). Implement Sci. 2014 Oct 23;9:157. doi: 10.1186/s13012-014-0157-1. PubMed 25338781 ↗
  • Batterham P, Allenhof C, Cerga Pashoja A, Etzelmueller A, Fanaj N, Finch T, Freund J, Hanssen D, Mathiasen K, Piera Jiminez J, Qirjako G, Rapley T, Sacco Y, Samalin L, Schuurmans J, van Genugten C, Vis C. Psychometric properties of two implementation measures: Normalization MeAsure Development questionnaire (NoMAD) and organizational readiness for implementing change (ORIC). Implement Res Pract. 2024 Apr 28;5:26334895241245448. doi: 10.1177/26334895241245448. eCollection 2024 Jan-Dec. PubMed 38686322 ↗
  • Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3. PubMed 28851459 ↗
  • Gustafson P, Lambert M, Bartholomew K, Ratima M, Aziz YA, Kremer L, Fusheini A, Carswell P, Brown R, Priest P, Crengle S. Adapting an equity-focused implementation process framework with a focus on ethnic health inequities in the Aotearoa New Zealand context. Int J Equity Health. 2024 Jan 27;23(1):15. doi: 10.1186/s12939-023-02087-y. PubMed 38280997 ↗
  • McCreight MS, Rabin BA, Glasgow RE, Ayele RA, Leonard CA, Gilmartin HM, Frank JW, Hess PL, Burke RE, Battaglia CT. Using the Practical, Robust Implementation and Sustainability Model (PRISM) to qualitatively assess multilevel contextual factors to help plan, implement, evaluate, and disseminate health services programs. Transl Behav Med. 2019 Nov 25;9(6):1002-1011. doi: 10.1093/tbm/ibz085. PubMed 31170296 ↗
  • Jolles MP, Fort MP, Glasgow RE. Aligning the planning, development, and implementation of complex interventions to local contexts with an equity focus: application of the PRISM/RE-AIM Framework. Int J Equity Health. 2024 Feb 27;23(1):41. doi: 10.1186/s12939-024-02130-6. PubMed 38408990 ↗
  • Glasgow RE, Trinkley KE, Ford B, Rabin BA. The Application and Evolution of the Practical, Robust Implementation and Sustainability Model (PRISM): History and Innovations. Glob Implement Res Appl. 2024;4(4):404-420. doi: 10.1007/s43477-024-00134-6. Epub 2024 Aug 31. PubMed 39568619 ↗
  • Ford I, Norrie J. Pragmatic Trials. N Engl J Med. 2016 Aug 4;375(5):454-63. doi: 10.1056/NEJMra1510059. No abstract available. PubMed 27518663 ↗
  • Hu GP, Zhan SY. [The PRECIS-2 tool: designing trials that are fit for purpose]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Feb 10;39(2):222-226. doi: 10.3760/cma.j.issn.0254-6450.2018.02.017. Chinese. PubMed 29495210 ↗
  • Landes SJ, McBain SA, Curran GM. Reprint of: An introduction to effectiveness-implementation hybrid designs. Psychiatry Res. 2020 Jan;283:112630. doi: 10.1016/j.psychres.2019.112630. Epub 2019 Nov 10. PubMed 31722790 ↗
  • Mau MK, West MR, Shara NM, Efird JT, Alimineti K, Saito E, Sugihara J, Ng R. Epidemiologic and clinical factors associated with chronic kidney disease among Asian Americans and Native Hawaiians. Ethn Health. 2007 Apr;12(2):111-27. doi: 10.1080/13557850601081720. PubMed 17364897 ↗
  • Grandinetti A, Kaholokula JK, Theriault AG, Mor JM, Chang HK, Waslien C. Prevalence of diabetes and glucose intolerance in an ethnically diverse rural community of Hawaii. Ethn Dis. 2007 Spring;17(2):250-5. PubMed 17682354 ↗
  • Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, Gu D, Feigin V, Jamrozik K, Ohkubo T, Woodward M; Asia-Pacific Cohort Studies Collaboration. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens. 2007 Jan;25(1):73-9. doi: 10.1097/HJH.0b013e328010775f. PubMed 17143176 ↗
  • Davis J, Busch J, Hammatt Z, Novotny R, Harrigan R, Grandinetti A, Easa D. The relationship between ethnicity and obesity in Asian and Pacific Islander populations: a literature review. Ethn Dis. 2004 Winter;14(1):111-8. PubMed 15002930 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Sep 2028, 28 months after the start.

Of 1,403 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 28 months is above that.

Counting every sponsor, half of 1,498 studies reached it within 23 months; a quarter within 10 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 27, 2026
First posted
Feb 4, 2026
StartActual
May 1, 2026
Primary completionEst.
Sep 15, 2028
CompletionEst.
Oct 31, 2028
Last update
Jun 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07387393
Lead sponsor
University of Hawaii
Collaborators
National Association of Pasifika Organizations, Papa Ola Lōkahi, National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Sponsor
First posted
Feb 4, 2026
Start date
May 1, 2026
Primary completion
Sep 15, 2028 (estimated)
Completion
Oct 31, 2028 (estimated)
Last update
Jun 9, 2026

Study contacts

Joseph K Kaholokula, PhD
principal investigator · University of Hawaii, Department of Native Hawaiian Health
Nia Aitaoto, PhD
principal investigator · National Association of Pasifika Organizations
Sheri-Ann Daniels, EdD
principal investigator · Papa Ola Lokahi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion